Compare ImmunityBio Inc. Common Stock (IBRX) vs PACCAR Inc. Common Stock (PCAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs PACCAR Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while PACCAR Inc. Common Stock trades at $109.72 (market cap $56.25B). The key difference: PACCAR Inc. Common Stock is far larger — about 5.4× ImmunityBio Inc. Common Stock's market cap, and PACCAR Inc. Common Stock pays a 1.31% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and PACCAR Inc. Common Stock for 0 Days on average.
| IBRX | PCAR | |
|---|---|---|
Market Cap | $10.33B | $56.25B |
Volume | 11,745,198 | 4,174,670 |
Sector | Health | Industrials |
52-Week High | $11.55 | $138.21 |
52-Week Low | $1.98 | $93.00 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $62.11B |
Dividend Yield | — | 1.31% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About PACCAR Inc. Common Stock
PACCAR designs and manufactures heavy-duty trucks under brands including Peterbilt, Kenworth, and DAF. It also provides parts, financial services, and technology for commercial vehicles.
Read more on PCAR →
